Middle East & Africa Stem Cell Therapy Market Forecast to 2028
Middle East & Africa Stem Cell Therapy Market Forecast to 2028 – Regional Analysis – by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management Drive Middle East & Africa Stem Cell Therapy Market
Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medicals conditions, including immune system diseases, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and cancer types such as leukemia and lymphoma.
Middle East & Africa Stem Cell Therapy Market Overview
Research and development for stem cells in UAE are gaining a rapid pace. Moreover, devising strategic policies and an increasing number of research partnerships & collaborations are projected to offer lucrative opportunities for the growth of the UAE stem cell therapy market during the forecast period. For instance, in 2019, Dubai Healthcare City announced an increase in stem cell banking services. The hospital and ReGen Medical Management entered into a partnership to offer a range of specialty regenerative services in the UAE. By September 2019, the hospital conducted around 600 successful stem cell therapy procedures.
Increasing awareness of benefits served by stem cell therapies and to offer these novel therapeutics for the treatment of chronic conditions, a significant number of investors and industry players are entering into the Middle East & Africa Stem Cell Therapy Market market. For instance, in September 2019, BRS Group announced a plan to open a stem cell research company in Abu Dhabi. Such aforementioned factors are responsible for influential growth of stem cell therapy in the UAE thereby dominating the overall market growth during the forecast period.
Middle East & Africa Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Stem Cell Therapy Market Segmentation
The Middle East & Africa Stem Cell Therapy Market is segmented into type, treatment, application, end user, and country.
Based on type, the Middle East & Africa Stem Cell Therapy Market is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment registered a largest share in the Middle East & Africa Stem Cell Therapy Market. The adult stem cell therapy segment is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.
Based on treatment, the Middle East & Africa Stem Cell Therapy Market is bifurcated into allogeneic and autologous. In 2022, the allogeneic segment registered a larger share in the Middle East & Africa Stem Cell Therapy Market.
Based on application, the Middle East & Africa Stem Cell Therapy Market is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. In 2022, the musculoskeletal segment registered the largest share in the Middle East & Africa Stem Cell Therapy Market.
Based on end user, the Middle East & Africa Stem Cell Therapy Market is bifurcated into hospitals & specialty clinics and academic & research institutes. In 2022, the academic & research institutes segment registered a larger share in the Middle East & Africa Stem Cell Therapy Market.
Based on country, the Middle East & Africa Stem Cell Therapy Market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. In 2022, the UAE registered the largest share in the Middle East & Africa Stem Cell Therapy Market.
Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited) are the leading companies operating in the Middle East & Africa Stem Cell Therapy Market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the Middle East & Africa stem cell therapy market was valued at US$ 53.25 million in 2022 and is expected to reach US$ 96.12 million by 2028, registering a CAGR of 10.3% from 2022 to 2028. Use of induced pluripotent stem cells in regenerative medicines and research activities and product innovations are the critical factors attributed to the Middle East & Africa stem cell therapy market expansion.
Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation in patients for treating injuries and degenerative diseases. Studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results. The aforementioned factors are expected to offer lucrative growth opportunities to companies in the Middle East & Africa stem cell therapy market in the coming years.
On the contrary, high cost of approved treatments hurdles the growth of Middle East & Africa stem cell therapy market.
Based on type, the Middle East & Africa stem cell therapy is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held 60.0% share of Middle East & Africa stem cell therapy market in 2022, amassing US$ 31.95 million. It is projected to garner US$ 58.82 million by 2028 to expand at 10.7% CAGR during 2022–2028. The adult stem cell therapy segments is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.
Based on treatment, the Middle East & Africa stem cell therapy is bifurcated into allogeneic and autologous. The allogeneic segment held 55.9% share of Middle East & Africa stem cell therapy market in 2022, amassing US$ 29.79 million. It is projected to garner US$ 53.03 million by 2028 to expand at 10.1% CAGR during 2022–2028.
Based on application, the Middle East & Africa stem cell therapy is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. The musculoskeletal segment held 33.2% share of Middle East & Africa stem cell therapy market in 2022, amassing US$ 17.66 million. It is projected to garner US$ 31.46 million by 2028 to expand at 10.1% CAGR during 2022–2028.
Based on end user, the Middle East & Africa stem cell therapy is bifurcated into hospitals & specialty clinics and academic & research institutes. The academic & research institutes segment held 53.5% share of Middle East & Africa stem cell therapy market in 2022, amassing US$ 28.51 million. It is projected to garner US$ 52.16 million by 2028 to expand at 10.6% CAGR during 2022–2028.
Based on country, the Middle East & Africa stem cell therapy is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the UAE captured 43.4% share of Middle East & Africa stem cell therapy market in 2022. It was assessed at US$ 23.09 million in 2022 and is likely to hit US$ 42.98 million by 2028, exhibiting a CAGR of 10.9% CAGR during 2022–2028.
Key players profiled in the Middle East & Africa stem cell therapy market report Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited), among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA America stem cell therapy market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the MEA stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the stem cell therapy market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Stem Cell Therapy Market – By Type
1.3.2 Middle East & Africa Stem Cell Therapy Market – By Treatment
1.3.3 Middle East & Africa Stem Cell Therapy Market – By Application
1.3.4 Middle East & Africa Stem Cell Therapy Market – By End User
1.3.5 Middle East & Africa Stem Cell Therapy Market – By Country
2. Middle East & Africa Stem Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Stem Cell Therapy Market– Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Stem Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Stem Cell Therapy Market – Middle East & Africa Analysis
6.1 Middle East & Africa Stem Cell Therapy Market Revenue Forecast and Analysis
7. Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Middle East & Africa Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Treatment
8.1 Overview
8.2 Middle East & Africa Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Application
9.1 Overview
9.2 Middle East & Africa Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Overview
11.1.1 Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
11.1.1.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 Saudi Arabia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.1.2.1 Saudi Arabia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.1.3 Saudi Arabia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.1.4 Saudi Arabia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.1.5 Saudi Arabia: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.1.1.2 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 UAE: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.2.2.1 UAE: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.2.3 UAE: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.2.4 UAE: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.2.5 UAE: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.1.1.3 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 South Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.3.2.1 South Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.3.3 South Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.3.4 South Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.3.5 South Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.1.1.4 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.4.2 Rest of Middle East and Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.4.2.1 Rest of Middle East and Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.4.3 Rest of Middle East and Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.4.4 Rest of Middle East and Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.4.5 Rest of Middle East and Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
12. Middle East & Africa Stem Cell Therapy Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 TiGenix NV (Takeda Pharmaceutical Company Limited)
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Lonza Group AG
13.2.1 Business Description
13.2.2 Products and Services
13.2.3 Financial Overview
13.2.4 SWOT Analysis
13.2.5 Key Developments
13.3 Pluri Inc
13.3.1.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East and Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East and Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East and Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East and Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 21. Organic Developments in the Middle East & Africa stem cell therapy market
Table 22. Inorganic Developments in the Middle East & Africa stem cell therapy market
Table 23. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Stem Cell Therapy Market Segmentation
Figure 2. Middle East & Africa Stem Cell Therapy Segmentation, By Country
Figure 3. Middle East & Africa Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Middle East & Africa Stem Cell Therapy Market
Figure 5. Middle East & Africa Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Middle East & Africa Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Adult Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Hematopoietic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Umbilical Cord Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Neuronal Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Mesenchymal Stem Cell: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Embryonic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Induced Pluripotent Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Other Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East & Africa Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 20. Allogeneic: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Middle East & Africa Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 23. Musculoskeletal: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Dermatology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Cardiology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Drug Discovery and Development: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Academic & Research Institutes: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Hospitals & Specialty Clinics: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Middle East & Africa Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
Figure 33. Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
The List of Companies – Middle East & Africa Stem Cell Therapy Market
o Lonza Group AG
o Pluri Inc
o Smith & Nephew Plc
o TiGenix NV (Takeda Pharmaceutical Company Limited)
You must be logged in to post a review.
Reviews
There are no reviews yet.